Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas Vera Grigorieva, MD, Mario Chen-Mok, PhD, Marina.

Slides:

Advertisements

Similar presentations

Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice Michelle Nisolle, M.D., Ph.D., Françoise Casanas-Roux, B.S.,

Advertisements

High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the.

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States David B. Seifer, M.D., Valerie.

Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences

Carlos Morán, M. D. , Eric Knochenhauer, M. D. , Larry R Boots, Ph. D

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study David F. Archer,

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Development of leiomyomas on the uterine remnants of two women with Mayer- Rokitansky-Küster-Hauser syndrome Efthimios Deligeoroglou, M.D., Antonios Kontoravdis,

The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome Silvia Ajossa, M.D., Stefano Guerriero, M.D.,

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.

The normal variabilities of the menstrual cycle

Long-term treatment of uterine fibroids with ulipristal acetate☆

Qi Shen, M. D. , Ying Hua, M. D. , Ph. D. , Wenxiao Jiang, M. D

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study David F. Archer,

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

A randomized trial comparing monopolar electrodes using glycine 1

Hongxia Li, M. D. , Jiangang Chen, M. D. , James W Overstreet, M. D

A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin)

Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids Isabelle.

John A Rock, M.D., Carla P Roberts, MD, PhD, John S Hesla, M.D.

Long-term treatment of uterine fibroids with ulipristal acetate☆

Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata Ibrahim Sozen, M.D., Aydin Arici,

Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing.

Levonorgestrel effects on serum androgens, sex hormone–binding globulin levels, hair shaft diameter, and sexual function George Kovalevsky, M.D., Susan.

Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women Raymond W Ke,

A comparison of blood spot vs

Christine L Cook, M. D. , Yong Siow, Ph. D. , Susan Taylor, B. A

Long-term follow-up after quinacrine sterilization in Vietnam

A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study Paolo Vercellini, M.D.,

Robert F. Casper, M.D. Fertility and Sterility

A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant Dan Apter, M.D., Ph.D.,

Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),

Success of intrauterine insemination in women aged 40–42 years

Induction of endometrial plasminogen activator–inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment.

Rodrigo Borsari, M. D. , Nilo Bozzini, Ph. D

Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia Bilian Xiao, M.D., Shang-Chun Wu,

From partner's desk to iPad

Administration of goserelin acetate after uterine artery embolization does not change the reduction rate and volume of uterine myomas George A. Vilos,

Uterine artery embolization for fibroids does not have adverse effects on ovarian reserve in regularly cycling women younger than 40 years Giovanna Tropeano,

Heterotopic cervical pregnancy successfully treated with transvaginal ultrasound-guided aspiration and cervical-stay sutures Dehan Chen, M.D., Isaac.

Frequency and effect of vaginal bleeding on pregnancy outcome during the first 3 weeks after positive β-hCG test results following IVF-ET Glen E Hofmann,

Masaaki Iwahashi, M.D., Yasuteru Muragaki, M.D.

Serum ionized magnesium and calcium in women after menopause: inverse relation of estrogen with ionized magnesium Ozgul Muneyyirci-Delale, M.D., Vijaya.

Serum Alkalinization and Hydrogen-Rich Water in Healthy Men

Hongxia Li, M. D. , Steven T Nakajima, M. D. , Jiangang Chen, M. D

Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences

Jcoe Glenn Proctor, B.S., William R. Boone, Ph.D.

One intrauterine device lost, two found

Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine.

Preferences for fertility in women with pelvic inflammatory disease

Regulation of assisted reproductive technologies in the United States

Effect of endometriosis on in vitro fertilization

Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis Xinmei Zhang, M.D., Jun Lin, M.D., Yuli Qian,

David Sokal, M. D. , Deborah Gates, Ramesh Amatya, Ph. D

Menstrual status and serum leptin levels in anorectic and in menstruating women with low body mass indexes Costantino Di Carlo, M.D., Giovanni A Tommaselli,

Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.

Olav Istre, M.D., Ph.D., Birgitta Trolle, M.D. Fertility and Sterility

Oral contraceptives improve lung mechanics

Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of.

Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute–

Jeffrey M Goldberg, M. D. , Edward Mascha, M. S. , Tommaso Falcone, M

Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study Xiaobin Wang, M.D., Changzhong Chen, M.D., Lihua.

Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome

Thomas M Price, M.D., Susan Allen, R.N., G.Vernon Pegram, M.D.

Expression of von willebrand’s factor, CD34, CD31, and vascular endothelial growth factor in uterine leiomyomas Christophe Poncelet, M.D., Patrick Madelenat,

Use of recombinant human chorionic gonadotropin in ovulation induction

Stephen J Winters, M. D. , Evelyn Talbott, David S Guzick, Ph. D. , M

Xuan Bich Trinh, M. D. , Wiebren A. A. Tjalma, M. D. , Ph. D. , Amin P

Presentation transcript:

Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas Vera Grigorieva, MD, Mario Chen-Mok, PhD, Marina Tarasova, MD, PhD, Anton Mikhailov, MD, PhD Fertility and Sterility Volume 79, Issue 5, Pages 1194-1198 (May 2003) DOI: 10.1016/S0015-0282(03)00175-4

FIGURE 1 Estimated menstrual blood loss (mean ± SD) before and after insertion of the levonorgestrel-releasing intrauterine system. *P<.001 vs. baseline; PBAC = pictorial blood loss assessment chart. Grigorieva. Levonorgestrel IUS in women with leiomyoma. Fertil Steril 2003. Fertility and Sterility 2003 79, 1194-1198DOI: (10.1016/S0015-0282(03)00175-4)

FIGURE 2 Blood hemoglobin level (mean ± SD) before and after insertion of the levonorgestrel-releasing intrauterine system. *P<.001 vs. baseline. Grigorieva. Levonorgestrel IUS in women with leiomyoma. Fertil Steril 2003. Fertility and Sterility 2003 79, 1194-1198DOI: (10.1016/S0015-0282(03)00175-4)

FIGURE 3 Serum ferritin level (mean ± SD) before and after insertion of the levonorgestrel-releasing intrauterine system. *P<0.001 vs. baseline. Grigorieva. Levonorgestrel IUS in women with leiomyoma. Fertil Steril 2003. Fertility and Sterility 2003 79, 1194-1198DOI: (10.1016/S0015-0282(03)00175-4)